Congress

Anna Eshoo

Politics

A congresswoman from Silicon Valley wants to lead on health care. New attack ads say she’s ‘in the pocket of Big Pharma’

By Rebecca Robbins

Capcapitol building/pharma illo

First Opinion

Congress needs a commission, not the pharma industry, for its drug policy ideas

By Scott Levy

advertisement

Nursing home patient

First Opinion

Grassley: Congressional oversight of health care is essential for a healthy America

By Chuck Grassley

advertisement

Rep. Chris Collins (R-NY)

Politics

‘How are these results even possible?’: Inside Rep. Chris Collins’ painful biotech education

By Damian Garde

Politics

Drug pricing could be a slam-dunk campaign issue for Democrats — if only they had a plan

Politics

Congress requests Sackler deposition that Purdue Pharma is fighting to keep sealed

By Andrew Joseph

SNAP

First Opinion

Dear Congress: SNAP work requirements will harm health, not improve nutrition

By Andrew Goldstein and Akash Goel

advertisement

An illustration of the NIH building surrounded by alcohol bottles and a football field.

Politics

Series of ethical stumbles tests NIH’s reliance on private sector for research funding

advertisement

Marijuana grown at the University of Mississippi.

Politics

The DEA wanted new suppliers of marijuana for research. Two years later, nothing has changed

By Andrew Joseph

Sen. Susan Collins, R-Maine, and Sen. Claire McCaskill, D-Mo., confer on Capitol Hill.

Politics

Senate committee advances bill to eliminate ‘gag clauses’ limiting disclosures on drug prices

By Erin Mershon

Opioid Privacy Laws

First Opinion

Treatment privacy laws protect me and 43 million other Americans living with addiction or in recovery

By Robert D. Ashford

Sen. Claire McCaskill Opioids

Politics

System for reporting suspicious opioid orders repeatedly failed, report finds

Politics

In subtle mixing of messages, the drug industry tries to press Congress to lift burden for more drug costs

By Erin Mershon

Politics

Signaling concern over industry funding, Congress presses for transparency at groups supporting NIH, CDC

Politics

Top Democrat demands PhRMA, BIO do more on gender issues after party with topless dancers

By Erin Mershon

Roy Blunt NIH

Politics

With bipartisan backing, Congress appears likely to increase NIH budget yet again

Biosimilars Lobbying

Politics

As the drug industry eyes the burgeoning biosimilar market, its united front is starting to crack

By Erin Mershon

Ryan, McCarthy, Walden Opioids

Politics

What’s in the House’s bills to address the opioid crisis — and what’s not

DNA Samples - Congress

Politics

Lawmakers press genetic testing companies for details on their privacy policies

By Megan Thielking

Lamar Alexander 340B

Politics

Key lawmaker calls for more scrutiny of hospitals using drug discount program — but no broader changes

By Erin Mershon

Chuck Grassley CREATES

Politics

Bill to encourage generic-drug development passes a key hurdle

By Erin Mershon

Pharmalot

Pharmalittle: Feds fight bid to disclose opioid shipments; Allergan moves to appease critics

By Ed Silverman

Paul Ryan, Kevin McCarthy, Greg Walden

Politics

Major opioids legislation is taking shape. Can it make a dent in a national epidemic?

Prescription benefit managers

Politics

FDA broadens guidelines on what information drug makers can share with insurers

By Ike Swetlitz

Alex Azar Senate Health Committee

Politics

Drug makers considering ‘substantial’ decreases in prices, Azar says

By Ike Swetlitz and Erin Mershon

Pharma

Drug pricing advocates take aim at Democrats for supporting pharma

By Erin Mershon

Opioid Lobbying

Politics

As opioids legislation gains steam, efforts to address crisis collide with moneyed interests

Antibiotics Pharmacy

Politics

Lawmakers advocate for new antibiotics, but stop short of offering incentives

By Ike Swetlitz

Pharmalot

Pharmalittle: Philippine official blames deaths on Sanofi dengue vaccine; Pfizer wants you to know it still invests in neuroscience

By Ed Silverman